Amyloid Precursor Protein

The mechanism by which the A4 (β-amyloid) domain of the Alzheimer amyloid precursor protein (APP) is deposited in plaques is unknown, and limited information is available concerning the extent to which other APP sites are associated with plaques. To address these issues, we prepared antiserum to a peptide adjacent to the N-terminus of the APP (referred to as N1) and examined its distribution in brain relative to A4 by double-immunostaining techniques. Anti-N1 localized to both neurons and glia in control and Alzheimer patients. In the Alzheimer brain, anti-N1 detected plaques. Quantitation revealed that 85% of thioflavin-positive plaques, and 91% of A4-positive plaques were also N1 positive. Double-staining methods directly demonstrated colocalization of distant APP sites. The data suggest that proposed mechanisms for amyloid deposition during plaque formation must take into account the extracytoplasmic domain, in addition to the A4 region, rather than be confined exclusively to the A4 site. (J Geriatr Psychiatry Neurol 1990;3:139-145).

[1]  J. Trojanowski,et al.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Benes,et al.  Evidence for a diffusional model of Alzheimer amyloid A4 (β-amyloid) deposition during neuritic plaque formation , 1989, Neuroscience.

[3]  N. Robakis,et al.  Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. , 1989, Biochemical and biophysical research communications.

[4]  C. Marotta,et al.  Monoclonal Antibody to Embryonic CNS Antigen A2B5 Provides Evidence for the Involvement of Membrane Components at Sites of Alzheimer Degeneration and Detects Sulfatides as Well as Gangliosides , 1989, Journal of neurochemistry.

[5]  F. Tagliavini,et al.  Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization. , 1989, Biochemical and biophysical research communications.

[6]  D. Selkoe,et al.  The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Cole,et al.  Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Tabaton,et al.  The amyloid precursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types , 1988, FEBS letters.

[9]  D. Selkoe,et al.  Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques. , 1988, Biochemical and biophysical research communications.

[10]  F. Benes,et al.  Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Marotta,et al.  Genetic Expression of Amyloid and Glial‐specific Protein in the Alzheimer Brain , 1988, Journal of the American Geriatrics Society.

[12]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.

[13]  G. Multhaup,et al.  Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. , 1988, The EMBO journal.

[14]  C. Marotta,et al.  Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[17]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[18]  F. Benes,et al.  Immunostaining of neurofilament protein in human postmortem cortex: a sensitive and specific approach to the pattern analysis of human cortical cytoarchitecture. , 1985, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[19]  G. Perry,et al.  Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Masters,et al.  AMYLOID PLAQUE CORE PROTEIN IN ALZHEIMERʼS DISEASE AND AGED DOWNʼS SYNDROME , 1985 .

[21]  C. Marotta,et al.  Axonal Polypeptides Cross‐Reactive with Antibodies to Neurofilament Proteins , 1983, Journal of neurochemistry.

[22]  C. Marotta,et al.  Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Chou,et al.  Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer brain. Coding and non-coding regions of the fetal precursor mRNA are expressed in the Alzheimer cortex , 1988 .

[24]  K. Grzeschik,et al.  The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor , 1987 .

[25]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.